Price T Rowe Associates Inc Adaptive Biotechnologies Corp Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 159,823 shares of ADPT stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,823

Previous 158,807 0.64%

Holding current value

$1.01 Million

Previous $575,000 42.43%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $3,423 - $5,201	1,016 Added 0.64%	159,823 $819,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $8,372 - $14,168	3,578 Added 2.3%	158,807 $575,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $396,446 - $660,744	-137,655 Reduced 47.0%	155,229 $499,000
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $54,899 - $84,571	-15,867 Reduced 5.14%	292,884 $1.44 Million
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $6.28 Million - $10.5 Million	-1,238,541 Reduced 80.05%	308,751 $1.68 Million
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $1.31 Million - $1.86 Million	-211,657 Reduced 12.03%	1,547,292 $10.4 Million
Q1 2023 May 15, 2023	SELL	$7.8 - $10.11 $620,232 - $803,916	-79,517 Reduced 4.33%	1,758,949 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $335,648 - $500,792	-53,618 Reduced 2.83%	1,838,466 $14 Million
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $66.9 Million - $130 Million	-10,291,811 Reduced 84.47%	1,892,084 $13.5 Million
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $1.49 Million - $3.42 Million	-232,472 Reduced 1.87%	12,183,895 $98.6 Million
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $8.81 Million - $25.2 Million	-870,346 Reduced 6.55%	12,416,367 $172 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $46.3 Million - $67.8 Million	1,840,491 Added 16.08%	13,286,713 $373 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $14.4 Million - $19.1 Million	479,331 Added 4.37%	11,446,222 $389 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $43.3 Million - $59.9 Million	1,342,666 Added 13.95%	10,966,891 $448 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $137 Million - $249 Million	3,669,449 Added 61.62%	9,624,225 $387 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $268 Million - $390 Million	5,954,776 New	5,954,776 $352 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $899M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Adaptive Biotechnologies Corp Transaction History